Compare MakeMyTrip Ltd (MMYT) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MakeMyTrip Ltd vs Altria Group Inc — how do they compare? MakeMyTrip Ltd trades at $56.43 (market cap $5.05B), while Altria Group Inc trades at $73.25 (market cap $124.67B). The key difference: Altria Group Inc is far larger — about 24.7× MakeMyTrip Ltd's market cap, and Altria Group Inc pays a 5.68% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals.
| MMYT | MO | |
|---|---|---|
Market Cap | $5.05B | $124.67B |
Sector | Technology | Consumer Staples |
52-Week High | $103.21 | $74.66 |
52-Week Low | $36.30 | $54.72 |
Enterprise Value | $5.69B | $145.75B |
Dividend Yield | — | 5.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
